Safety of RSV Preventive Monoclonal Antibody (NCT07158814)

🧪 Interventions in This Study

• Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (6 Sites)

• Kaiser Permanente Northern California — Oakland, California
• Emory University — Atlanta, Georgia
• Centers for Disease Control and Prevention — Atlanta, Georgia
• Columbia University — New York, New York
• Duke University — Durham, North Carolina
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio

📞 Contact the Study Coordinator

Phone: (919) 684-6335

Email: michael.j.smith@duke.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Fever

• Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department — Austin, Texas
• Remote Temperature Monitoring of Patients At Risk for Developing Fever — Schenectady, New York

Explore by condition: All Fever clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.